How people get it: By prescription. Some doctors prescribe low doses off-label for aging.
Part of Age reversal: drugs and supplements studied for slowing aging
The basics
What it is
- Rapamycin is another name for sirolimus, which is sold under the brand name Rapamune.
- Sirolimus belongs to a class of drugs called immunosuppressants.
- The label calls sirolimus an mTOR inhibitor immunosuppressant.
Sources: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗ · DailyMed (FDA drug label): DailyMed - SIROLIMUS tablet, sugar coated ↗
How it's thought to work
It works by suppressing the body's immune system. In lab studies, mTOR inhibitors like sirolimus blocked certain growth factors that may affect blood vessel growth, scar-forming cells, and vessel leakiness.
Sources: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗ · DailyMed (FDA drug label): DailyMed - SIROLIMUS tablet, sugar coated ↗
What people use it for
- It is used with other medicines to prevent rejection of kidney transplants.
- It is also used to treat lymphangioleiomyomatosis, a rare lung condition.
- It is sometimes used to prevent organ rejection in people with heart, pancreas, or intestinal transplants.
Source: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗
What the research has found so far
Extends lifespan in mice. Human studies so far are small.
On Rapamycin and aging, PubMed lists 25 trials in people, 36 studies that watched people over time, 1,020 animal and lab studies. See the counts and searches
Stage 2 because 25 published trials and 40 registered trials in people have been found, but no large ones yet.
A stage shows how far research has got, not whether it will work for you. How stages work
Side effects and risks
- Common side effects listed include stomach pain, headache, constipation, diarrhea, nausea, joint or muscle pain, mouth sores, and acne.
- In transplant patients, the most common reactions (30% or more) included swelling in the limbs, high blood fats, high blood pressure, fever, urinary infection, anemia, and low platelets.
- Sirolimus may raise the risk of cancer, especially lymphoma or skin cancer.
- Cholesterol and triglycerides rose more often in sirolimus patients than in placebo patients.
- Reports include slow or delayed wound healing.
- Serious lung disease, some fatal, has occurred in people on regimens including sirolimus.
- It may cause too little or no sperm in men.
- Sirolimus has been linked to allergic reactions and swelling under the skin called angioedema.
- Increased protein in the urine was commonly seen in patients switched to sirolimus.
Sources: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗ · DailyMed (FDA drug label): DailyMed - SIROLIMUS tablet, sugar coated ↗
Who should be careful, and drug interactions
- People should not become pregnant while taking it, and it may harm the fetus.
- Birth control is described for before, during, and 12 weeks after treatment.
- It may lower fertility in men and women.
- The label says breastfed infants could have serious effects.
- The page lists cimetidine, St. John's wort, and cannabidiol as products that may interact with it.
- The page says cyclosporine is taken 4 hours before sirolimus.
- The label says to avoid strong CYP3A4/P-gp inducers or inhibitors, which change sirolimus levels.
- Using ACE inhibitors with sirolimus may raise the risk of angioedema.
- Taking sirolimus with cholesterol drugs called HMG-CoA reductase inhibitors led to muscle-related reactions.
- The page says to tell doctors about high cholesterol or triglycerides, diabetes, or liver disease.
- The page says to tell the doctor or dentist about sirolimus before surgery.
- The label says live vaccines should be avoided.
- The page says to avoid grapefruit juice with this medicine.
- People with a BMI over 30 may be at higher risk of abnormal wound healing.
- It is contraindicated in people with a hypersensitivity (allergy) to sirolimus.
Sources: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗ · DailyMed (FDA drug label): DailyMed - SIROLIMUS tablet, sugar coated ↗
Amounts used in studies
What studies or labels describe, not a recommendation.
- It comes as a tablet and a liquid solution taken by mouth once a day.
- The label lists tablets of 0.5 mg, 1 mg, and 2 mg.
- For kidney transplant patients at low to moderate risk, the label lists a 6 mg loading dose on day 1, then 2 mg daily.
- For high-risk kidney transplant patients, the label lists a loading dose of up to 15 mg, then 5 mg daily.
- For lymphangioleiomyomatosis, the label lists an initial dose of 2 mg a day.
Sources: MedlinePlus (NIH): Sirolimus: MedlinePlus Drug Information ↗ · DailyMed (FDA drug label): DailyMed - SIROLIMUS tablet, sugar coated ↗
Roughly what it costs
We don't have prices for this yet.
Questions to ask your doctor
- Is Rapamycin a sensible option for me, given my health and the medicines I take?
- Could Rapamycin interact with any medicine or supplement I already take?
- What side effects should I watch for, and when should I stop or call you?
- Would Rapamycin be used for its approved purpose, or off-label for aging?
- How would we tell whether it is helping, and when should we review it?
This is general information gathered from the sources listed, not medical advice. Talk to your doctor before starting anything new.
What experts say
No expert views collected yet. Each one we add names the person and links to where they said it.
What others are writing
Recent articles about Rapamycin from health journalists, hospitals and universities. We link to them; we don't write or endorse them.
First national review of anti-aging compounds ↗
“The review found that the most effective compound tested through the ITP so far is rapamycin. Rapamycin was chosen because it inhibits the mammalian target of rapamycin (mTOR), a key protein that integrates signals from nutrients and hormones to regulate whether cells prioritize growth or shift toward repair and maintenance.”
A university review of two decades of NIH mouse studies found rapamycin to be the most effective compound tested for extending lifespan.
What is rapamycin? Devotees claim the drug can slow aging ↗
“Rapamycin is a naturally occurring compound primarily used to prevent organ rejection in transplant patients. It’s also considered a promising anti-aging drug among longevity seekers.”
The article explains rapamycin's use in transplant patients and its popularity among longevity seekers, while noting that benefits in people remain unclear.
Rapamycin is being studied to see if it can slow down age-related diseases in humans ↗
“Rapamycin was first approved by the FDA for transplant patients in the 1990s. At high doses, it suppresses the immune system. At low doses, it seems to help tamp down inflammation.”
A clinical trial will test rapamycin in gum disease, with researchers hoping it may help slow other age-related diseases.
Videos
Talks and interviews that name Rapamycin, from aging research institutes, scientific meetings, science outlets and longevity companies. We link to them; we don't make or endorse them.
Recent research
Ginseng compound Rb1 eased signs of aging in the uterus in lab tests
Researchers found that Rb1 reduced aging signs in uterus lining cells and mouse uteruses.
Apelin-13 protected brain cells from aging in cells and mice
Researchers found that apelin-13 helped brain cells resist aging signs by restoring their cleanup process.
Low-dose rapamycin appeared safe over one year in healthy adults
A trial gave people weekly rapamycin or a placebo for 48 weeks and checked side effects and blood tests.
A review proposes a link between two brain proteins and aging-related memory loss
This review looks at two brain proteins that help control inhibitory connections between nerve cells.
Trials
ClinicalTrials.gov lists 40 registered trials that mention Rapamycin, for any condition (the count in The science below). Here we show the ones about aging. See them all ↗
The science
Counted from PubMed and ClinicalTrials.gov on Oct 30, 2026, using one search for Rapamycin in relation to aging. Each link opens the exact search.
- Randomized trials in people
- 18 search ↗
- Large trials (multicenter or phase 3)
- 2 search ↗
- Phase 3 trials
- 1 search ↗
- Trials in people
- 25 search ↗
- Studies that watched people over time
- 36 search ↗
- Animal and lab studies
- 1,020 search ↗
- Registered trials
- 40 search ↗
PubMed search used
(rapamycin[tiab] OR sirolimus[tiab] OR rapalog*[tiab] OR "mTOR inhibitor*"[tiab]) AND (aging[tiab] OR ageing[tiab] OR longevity[tiab] OR lifespan[tiab] OR "life span"[tiab] OR healthspan[tiab] OR "Aging"[mh] OR "Longevity"[mh])
Counts are search results, so they include some records that only mention Rapamycin. How we count
Cite or share this page
Longevity Progress. (n.d.). Rapamycin: Research stage and evidence. Retrieved October 30, 2026, from https://longevityprogress.com/treatments/rapamycin
<iframe src="https://longevityprogress.com/embed/stage/rapamycin" title="Rapamycin: research stage on Longevity Progress" width="340" height="72" style="border:0" loading="lazy"></iframe>
The badge shows this treatment's current research stage and links back here. It updates by itself when the stage changes.
